OppenheimerFunds’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-5,410
Closed -$545K 1001
2014
Q4
$545K Buy
+5,410
New +$421K ﹤0.01% 894
2014
Q3
Sell
-567,755
Closed -$39.6M 1000
2014
Q2
$39.6M Buy
567,755
+33,180
+6% +$2.26M 0.04% 408
2014
Q1
$39.1M Buy
534,575
+143,330
+37% +$10.7M 0.05% 408
2013
Q4
$26.9M Buy
391,245
+36,440
+10% +$2.36M 0.03% 498
2013
Q3
$22.5M Sell
354,805
-46,090
-11% -$2.79M 0.03% 503
2013
Q2
$19.4M Buy
+400,895
New +$19.7M 0.03% 517

OppenheimerFunds's CBST Position: Q1 2015 in Review

OppenheimerFunds sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 5,410 shares — an estimated $545K sold.

OppenheimerFunds first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $39.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • OppenheimerFunds reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • OppenheimerFunds sold 5,410 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $545K.
  • OppenheimerFunds first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • OppenheimerFunds's CUBIST PHARMACEUTICALS INC position peaked at $39.6M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.